18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy...
18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma
About this item
Full title
Author / Creator
Publisher
Japan: Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Japan: Springer Japan
Subjects
More information
Scope and Contents
Contents
Objective
To evaluate the usefulness of [
18
F]fluoromisonidazole ([
18
F]FMISO)-positron emission tomography (PET) prior to the treatment of head and neck squamous cell carcinoma.
Methods
Seventeen patients with untreated HNSCC underwent pretreatment [
18
F]FMISO PET. Six of them underwent definitive surgery and the rema...
Alternative Titles
Full title
18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_926891170
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_926891170
Other Identifiers
ISSN
0914-7187,1864-6433
E-ISSN
1864-6433
DOI
10.1007/s12149-011-0508-9
